logo
Plus   Neg
Share
Email

Ceconomy Q3 Sales Down - Quick Facts

Ceconomy AG (MTAGF.PK,MTTRY.PK) reported that its third-quarter sales declined 8.4 per cent on a currency- and portfolio-adjusted basis to around 4.1 billion euros, reflecting the effects of the Corona crisis and was exclusively related to the COVID-19 lockdowns in April and partly in May.

Adjusted EBIT was negative 45 million euros, compared to negative 43 million euros in the prior year.Savings from the reorganization and efficiency program also had a positive effect on earnings.

Adjusted EBIT was negatively impacted by the decline in sales in the stationary business due to the store closures in April in combination with a lower gross margin for the full quarter.

For the full year, Ceconomy now expects only a slight decline of total sales adjusted for currency effects compared to the previous year. In addition, the company expects an EBIT between 165 million euros and 185 million euros, not taking into account the earnings effects from companies accounted for using the equity method.

On Wednesday, Ceconomy said that it may reduce up to 3,500 full-time jobs in the next 24 to 36 months, primarily in foreign European countries, due to implementation of new operating model.

MediaMarktSaturn was also reviewing the store portfolio throughout Europe, due to drop in customer frequencies as a result of the COVID-19 pandemic.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Santa Cruz Bicycles LLC has recalled certain model year 2020 bicycles with aluminum frames citing fall risks, according to the U.S. Consumer Product Safety Commission. The recall involves about 2,900 units of model year 2020 Auminum Santa Cruz and Juliana Bicycles. In addition, about 216 were sold in Canada. AstraZeneca is mulling an additional global trial to confirm the 90% efficacy rate of its Covid-19 vaccine candidate at lower dosage, Bloomberg news quoted Chief Executive Officer Pascal Soriot as saying. In an interview, Soriot noted that instead of adding the trial to an ongoing U.S. process, the company might launch a fresh study to evaluate efficacy of lower dosage of its vaccine that perform U.S. airline Delta Air Lines, Inc. and its Italian codeshare partner Alitalia are planning to launch quarantine-free, COVID-free flights between U.S. and Europe through new testing protocols, starting in December. In a statement, Delta said it has signed deals with airports and governments eliminating quarantine requirements on COVID-tested flights connecting Atlanta and Rome.
Follow RTT